Suárez-Pinilla P
Suárez-Pinilla P
Médico Psiquiatra
بريد إلكتروني تم التحقق منه على humv.es
عنوانعدد مرات الاقتباساتالسنة
Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies
F Catalá-López, M Suárez-Pinilla, P Suárez-Pinilla, JM Valderas, ...
Psychotherapy and psychosomatics 83 (2), 89-105, 2014
1192014
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
MK Chan, MO Krebs, D Cox, PC Guest, RH Yolken, H Rahmoune, ...
Translational psychiatry 5 (7), e601-e601, 2015
942015
Gene-environment interactions underlying the effect of cannabis in first episode psychosis
J Maria Pelayo-Teran, P Suarez-Pinilla, N Chadi, B Crespo-Facorro
Current pharmaceutical design 18 (32), 5024-5035, 2012
462012
Immune system: a possible nexus between cannabinoids and psychosis
P Suárez-Pinilla, J López-Gil, B Crespo-Facorro
Brain, behavior, and immunity 40, 269-282, 2014
432014
Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study
B Crespo-Facorro, VOG de la Foz, R Ayesa-Arriola, R Pérez-Iglesias, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, 162-167, 2013
352013
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis
JM Pelayo-Teran, FJ Diaz, R Perez-Iglesias, P Suarez-Pinilla, ...
Psychological medicine 44 (1), 37-50, 2014
322014
Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables
I Díaz, JM Pelayo-Terán, R Pérez-Iglesias, I Mata, R Tabarés-Seisdedos, ...
Psychiatry research 206 (2-3), 181-187, 2013
302013
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis
R Pérez-Iglesias, VOG de la Foz, OM García, JA Amado, ...
Schizophrenia research 159 (1), 90-94, 2014
272014
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
E Walton, DP Hibar, TGM Van Erp, SG Potkin, R Roiz-Santiañez, ...
Psychological medicine 48 (1), 82-94, 2018
262018
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
E Walton, DP Hibar, TGM van Erp, SG Potkin, R Roiz‐Santiañez, ...
Acta Psychiatrica Scandinavica 135 (5), 439-447, 2017
252017
Brain structural effects of antipsychotic treatment in schizophrenia: a systematic review
R Roiz-Santiañez, P Suarez-Pinilla, B Crespo-Facorro
Current neuropharmacology 13 (4), 422-434, 2015
252015
Homocysteine and cognition: a systematic review of 111 studies
E Setién-Suero, M Suárez-Pinilla, P Suárez-Pinilla, B Crespo-Facorro, ...
Neuroscience & Biobehavioral Reviews 69, 280-298, 2016
242016
Brain structural and clinical changes after first episode psychosis: focus on cannabinoid receptor 1 polymorphisms
P Suárez-Pinilla, R Roiz-Santiañez, VOG de la Foz, PC Guest, ...
Psychiatry Research: Neuroimaging 233 (2), 112-119, 2015
222015
Inpatient treatment for anorexia nervosa: a systematic review of randomized controlled trials
P Suarez-Pinilla, C Pena-Perez, B Arbaizar-Barrenechea, ...
Journal of Psychiatric Practice® 21 (1), 49-59, 2015
212015
Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study
D Tordesillas-Gutierrez, N Koutsouleris, R Roiz-Santiañez, E Meisenzahl, ...
Schizophrenia research 164 (1-3), 74-82, 2015
192015
Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year
B Crespo-Facorro, VOG de la Foz, I Mata, R Ayesa-Arriola, ...
Psychopharmacology 231 (2), 357-366, 2014
162014
Aripiprazole, ziprasidone and quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial
B Crespo-Facorro, VOG de la Foz, I Mata, R Ayesa-Arriola, ...
Schizophrenia research 147 (2-3), 375-382, 2013
162013
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment
M Juncal-Ruiz, M Ramirez-Bonilla, J Gomez-Arnau, VOG de la Foz, ...
Psychopharmacology 234 (17), 2563-2570, 2017
152017
A disrupted-in-Schizophrenia 1 gene variant is associated with clinical symptomatology in patients with first-episode psychosis
J Vázquez-Bourgon, I Mata, R Roiz-Santiáñez, R Ayesa-Arriola, PS Pinilla, ...
Psychiatry investigation 11 (2), 186, 2014
152014
No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of …
R Roiz-Santiáñez, VOG de la Foz, R Ayesa-Arriola, ...
Psychological medicine 45 (13), 2861-2871, 2015
112015
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20